1 September 2024 false No description of principal activity Taxfiler 2024.6 14327803 business:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 14327803 2024-08-31 14327803 2024-09-01 2025-08-31 14327803 business:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 14327803 business:FilletedAccounts 2024-09-01 2025-08-31 14327803 2025-08-31 14327803 business:Director1 2024-09-01 2025-08-31 14327803 business:Director2 2024-09-01 2025-08-31 14327803 business:RegisteredOffice 2024-09-01 2025-08-31 14327803 2024-08-31 14327803 core:WithinOneYear 2025-08-31 14327803 core:WithinOneYear 2024-08-31 14327803 core:AfterOneYear 2025-08-31 14327803 core:AfterOneYear 2024-08-31 14327803 core:ShareCapital core:PreviouslyStatedAmount 2025-08-31 14327803 core:ShareCapital core:PreviouslyStatedAmount 2024-08-31 14327803 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-08-31 14327803 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-08-31 14327803 core:PreviouslyStatedAmount 2025-08-31 14327803 core:PreviouslyStatedAmount 2024-08-31 14327803 business:SmallEntities 2024-09-01 2025-08-31 14327803 countries:EnglandWales 2024-09-01 2025-08-31 14327803 core:ComputerEquipment 2024-09-01 2025-08-31 14327803 core:Goodwill 2024-08-31 14327803 core:Goodwill 2025-08-31 14327803 core:Goodwill 2024-09-01 2025-08-31 14327803 core:ComputerEquipment 2024-08-31 14327803 core:ComputerEquipment 2025-08-31 14327803 2023-09-01 2024-08-31 iso4217:GBP xbrli:pure
Company Registration No. 14327803 (England and Wales)
Weymouth Pharma Ltd Unaudited accounts for the year ended 31 August 2025
Weymouth Pharma Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Weymouth Pharma Ltd Company Information for the year ended 31 August 2025
Directors
Sunil Varghese Chacko Moyosoreoluwa Ogunfowoke
Company Number
14327803 (England and Wales)
Registered Office
Weymouth Pharmacy 26 Abbotsbury Road Weymouth Dorset DT4 0AE England
- 3 -
Weymouth Pharma Ltd Statement of financial position as at 31 August 2025
2025
2024
Notes
£
£
Fixed assets
Intangible assets
4
612,391
625,080
Tangible assets
5
3,173
3,966
615,564
629,046
Current assets
Inventories
60,000
89,000
Debtors
6
143,467
153,882
Cash at bank and in hand
111,915
27,363
315,382
270,245
Creditors: amounts falling due within one year
7
(474,519)
(439,954)
Net current liabilities
(159,137)
(169,709)
Total assets less current liabilities
456,427
459,337
Creditors: amounts falling due after more than one year
8
(428,288)
(458,000)
Net assets
28,139
1,337
Capital and reserves
Called up share capital
100
100
Profit and loss account
28,039
1,237
Shareholders' funds
28,139
1,337
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 2 May 2026 and were signed on its behalf by
Sunil Varghese Chacko Director Company Registration No. 14327803
- 4 -
Weymouth Pharma Ltd Notes to the Accounts for the year ended 31 August 2025
1
Statutory information
Weymouth Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 14327803. The registered office is Weymouth Pharmacy, 26 Abbotsbury Road, Weymouth, Dorset, DT4 0AE, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
20% reduce balance basis
4
Intangible fixed assets
Goodwill
£
Cost
At 1 September 2024
634,434
At 31 August 2025
634,434
Amortisation
At 1 September 2024
9,354
Charge for the year
12,689
At 31 August 2025
22,043
Net book value
At 31 August 2025
612,391
At 31 August 2024
625,080
- 5 -
Weymouth Pharma Ltd Notes to the Accounts for the year ended 31 August 2025
5
Tangible fixed assets
Computer equipment
£
Cost or valuation
At cost
At 1 September 2024
6,027
At 31 August 2025
6,027
Depreciation
At 1 September 2024
2,061
Charge for the year
793
At 31 August 2025
2,854
Net book value
At 31 August 2025
3,173
At 31 August 2024
3,966
6
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
17,462
40,967
Trade debtors
126,005
112,915
143,467
153,882
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
30,000
30,000
Trade creditors
186,866
153,002
Taxes and social security
13,829
2,335
Other creditors
12,771
14,856
Loans from directors
231,053
239,761
474,519
439,954
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans
428,288
458,000
9
Average number of employees
During the year the average number of employees was 10 (2024: 14).
- 6 -